Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€24.60
06.04.21
-
06.04.22
-34.15%
03.05.21

Good rating
Capable Management
Probably not worthwhile Investment
No Innovation
buy
Nordex SE

Start price
Target price
Perf. (%)
€26.52
06.04.21
€30.00
06.04.22
-12.97%
20.04.21

Sustainability is important
Known brand
Very Future proof/growth oriented business model
Higher risks for its business
buy
Encavis AG

Start price
Target price
Perf. (%)
€16.39
06.04.21
€18.50
06.04.22
-6.71%
29.05.21

Differentiated customer and product portfolio
Standard Investments for future growth
High valuation
Higher risks for its business
buy
Velodyne Lidar Inc.

Start price
Target price
Perf. (%)
€11.91
06.04.21
€3.00
06.04.22
-81.69%
07.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Adverum Biotechnologies Inc.

Start price
Target price
Perf. (%)
€8.60
06.04.21
€10.00
06.04.22
-15.12%
19.04.21

Could be worthwhile Investment >10% per year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€7.47
06.04.21
€9.00
06.04.22
-9.64%
19.04.21

Could be worthwhile Investment >10% per year
buy
Aravive, Inc.

Start price
Target price
Perf. (%)
€4.90
06.04.21
€6.00
06.04.22
-10.20%
19.04.21

Could be worthwhile Investment >10% per year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€7.65
06.04.21
€9.00
06.04.22
-12.68%
19.04.21

Could be very worthwhile Investment >20% year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.02
06.04.21
€60.00
06.04.22
3.82%
01.07.21

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Phunware Inc.

Start price
Target price
Perf. (%)
€1.64
06.04.21
€2.00
06.04.22
-22.93%
03.05.21

Could be worthwhile Investment >10% per year
Good culture
Capable Management
Little innovation
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€13.90
06.04.21
-
06.04.22
-22.73%
18.02.22

Undervalued
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
buy
Odonate Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.70
06.04.21
€5.00
06.04.22
-2.96%
03.05.21

Could be worthwhile Investment >10% per year
Innovative
Good culture
Few uniques
buy
First Solar Inc.

Start price
Target price
Perf. (%)
€71.30
06.04.21
-
06.04.22
-6.03%
09.04.21

Home Depot Inc.

Start price
Target price
Perf. (%)
€267.70
06.04.21
€170.00
06.04.22
1.98%
07.04.22

Known brand
Probably not worthwhile Investment
Low dividend yield expected
High valuation
Nordex SE

Start price
Target price
Perf. (%)
€28.60
06.04.21
€9.00
06.04.22
-40.24%
07.04.22

Sustainability is important
Risky balance sheet
Below average Marketposition
Bad rating
buy
Matinas BioPharma Holdings Inc

Start price
Target price
Perf. (%)
€0.93
06.04.21
€2.00
06.04.22
-25.41%
19.04.21

Could be worthwhile Investment >10% per year
buy
Organovo Holdings Inc.

Start price
Target price
Perf. (%)
€8.35
06.04.21
€10.00
06.04.22
-13.30%
19.04.21

Could be worthwhile Investment >10% per year
buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€69.62
06.04.21
€80.00
06.04.22
-17.38%
19.04.21

Could be worthwhile Investment >10% per year
buy
WAVE Life Sciences Ltd

Start price
Target price
Perf. (%)
€5.59
06.04.21
€7.00
06.04.22
-8.23%
19.04.21

Could be very worthwhile Investment >20% year
DMG Blockchain Solutions Inc.

Start price
Target price
Perf. (%)
€1.51
06.04.21
-
07.04.22
-6.08%
13.04.21

Top 10 in its market
Future proof or reliable business model
Higher risks for its business
overvalued
buy
Bigg Digital Assets Inc.

Start price
Target price
Perf. (%)
€1.80
06.04.21
-
06.04.22
-70.52%
07.04.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Risky balance sheet
Hive Digital Technologies Ltd.

Start price
Target price
Perf. (%)
€17.62
06.04.21
-
06.04.22
-3.80%
08.04.21

Revenue growth > 30% per year expected
Sustainability is important
Business model of the past or high risk
Low dividend yield expected
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€2.47
06.04.21
-
06.04.24
-84.62%
11.03.24

Could be worthwhile Investment >10% per year
buy
Lynas Corp. Ltd

Start price
Target price
Perf. (%)
€4.01
06.04.21
-
06.04.24
-12.77%
11.03.24

Could be worthwhile Investment >10% per year
buy
Millennial Lithium Corp

Start price
Target price
Perf. (%)
€2.29
06.04.21
-
06.04.24
19.21%
11.03.24

Could be worthwhile Investment >10% per year